Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Investigating the effect of verapamil on preservation of beta-cell function in adults with newly diagnosed type 1 diabetes mellitus (Ver-A-T1D): protocol for a randomised, double-blind, placebo-controlled, parallel-group, multicentre trial.
Wych J, Brunner M, Stenson R, Chmura PJ, Danne T, Mander AP, Mathieu C, Dayan C, Pieber TR. Wych J, et al. Among authors: mander ap. BMJ Open. 2024 Nov 28;14(11):e091597. doi: 10.1136/bmjopen-2024-091597. BMJ Open. 2024. PMID: 39613428 Free PMC article.
A personalised and systematically designed adherence intervention improves photoprotection in adults with Xeroderma Pigmentosum (XP): Results of the XPAND randomised controlled trial.
Walburn J, Norton S, Sarkany R, Canfield M, Sainsbury K, McCrone P, Araújo-Soares V, Morgan M, Boadu J, Foster L, Heydenreich J, Mander AP, Sniehotta FF, Wulf HC, Weinman J. Walburn J, et al. Among authors: mander ap. Br J Dermatol. 2024 Oct 15:ljae393. doi: 10.1093/bjd/ljae393. Online ahead of print. Br J Dermatol. 2024. PMID: 39401796
C286, an orally available retinoic acid receptor β agonist drug, regulates multiple pathways to achieve spinal cord injury repair.
Goncalves MB, Wu Y, Clarke E, Grist J, Moehlin J, Mendoza-Parra MA, Hobbs C, Kalindjian B, Fok H, Mander AP, Hassanin H, Bendel D, Täubel J, Mant T, Carlstedt T, Jack J, Corcoran JPT. Goncalves MB, et al. Among authors: mander ap. Front Mol Neurosci. 2024 Aug 20;17:1411384. doi: 10.3389/fnmol.2024.1411384. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39228795 Free PMC article.
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participants.
Goncalves MB, Mant T, Täubel J, Clarke E, Hassanin H, Bendel D, Fok H, Posner J, Holmes J, Mander AP, Corcoran JPT. Goncalves MB, et al. Among authors: mander ap. Br J Clin Pharmacol. 2023 Dec;89(12):3573-3583. doi: 10.1111/bcp.15854. Epub 2023 Aug 9. Br J Clin Pharmacol. 2023. PMID: 37452623 Free PMC article. Clinical Trial.
Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189-2201.
Anderson RL, DiMeglio LA, Mander AP, Dayan CM, Linsley PS, Herold KC, Marinac M, Ahmed ST. Anderson RL, et al. Among authors: mander ap. Diabetes Care. 2022 Dec 1;45(12):3113. doi: 10.2337/dc22-er12a. Diabetes Care. 2022. PMID: 36219765 Free PMC article. No abstract available.
81 results